Kent Imaging, a leading innovator in tissue oxygenation assessment, designs and manufactures imaging technology that supports realtime decision-making in wound care, vascular and surgical specialties. Unlike some devices that only measure the macrovasculature, SnapshotNIR utilizes near-infrared light to go below the surface and measure tissue oxygen saturation, oxyhemoglobin, deoxyhemoglobin and total hemoglobin in the microvascular network. Use actionable data to document medical necessity, expedite vascular assessment, design treatment plans, and track and document therapeutic efficacy.

The MolecuLight i:X® and DX™ point-of-care imaging devices enable detection of elevated bacterial loads and accurate digital wound measurement. They facilitate proactive wound care & inform clinician decision-making in real-time including enabling guided cleaning & debridement. US reimbursement pathway is enabled, along with 80+ peer-reviewed publications.